XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Class A Non-voting Common Stock
Class A Non-voting Common Stock
Common Stock
Class B Common Stock
Class B Common Stock
Common Stock
Class C Common Stock
Class C Common Stock
Common Stock
Balance, beginning of period, shares at Dec. 31, 2018           999,304   93,846   224,611
Balance, beginning of period at Dec. 31, 2018   $ 8,220,417 $ (5,912,578) $ 3,147   $ 10   $ 1   $ 2
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares           1,724   789    
Shares issued in connection with exercise of stock options under stock-based compensation plans   6,974                
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares           48,281   291    
Issuance of Class A non-voting common stock in connection with acquisitions and divestitures   6,913                
Conversion of stock to voting/non-voting common stock, shares           47,344   (47,344)    
Conversion of stock to voting/non-voting common stock           $ 1   $ (1)    
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   3,303
Stock-based compensation expense   358,130                
Net loss $ (565,581)   (565,581)   $ (440,465)   $ (22,440)   $ (102,676)  
Other comprehensive income (loss), net of tax $ (1,045)     (1,045)            
Balance, end of period, shares at Jun. 30, 2019 1,372,149         1,096,653   47,582   227,914
Balance, end of period at Jun. 30, 2019 $ 2,116,698 8,592,434 (6,477,851) 2,102   $ 11       $ 2
Balance, beginning of period, shares at Mar. 31, 2019           1,057,135   51,510   226,287
Balance, beginning of period at Mar. 31, 2019   8,388,608 (6,222,677) (68)   $ 11   $ 1   $ 2
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares           464   139    
Shares issued in connection with exercise of stock options under stock-based compensation plans   1,339                
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares           34,899   88    
Issuance of Class A non-voting common stock in connection with acquisitions and divestitures   6,913                
Conversion of stock to voting/non-voting common stock, shares           4,155   (4,155)    
Conversion of stock to voting/non-voting common stock               $ (1)    
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   1,627
Stock-based compensation expense   195,574                
Net loss (255,174)   (255,174)   (200,295)   (9,089)   (45,790)  
Other comprehensive income (loss), net of tax $ 2,170     2,170            
Balance, end of period, shares at Jun. 30, 2019 1,372,149         1,096,653   47,582   227,914
Balance, end of period at Jun. 30, 2019 $ 2,116,698 8,592,434 (6,477,851) 2,102   $ 11       $ 2
Cumulative-effect adjustment from accounting changes     308              
Balance, beginning of period, shares at Dec. 31, 2019           1,160,127   24,522   231,147
Balance, beginning of period at Dec. 31, 2019 2,259,913 9,205,256 (6,945,930) 573   $ 12       $ 2
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares           2,744   393    
Shares issued in connection with exercise of stock options under stock-based compensation plans   23,608                
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares           41,386        
Conversion of stock to voting/non-voting common stock, shares           700   (700)    
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   3,301
Stock-based compensation expense   358,404                
Equity component of convertible senior notes, net   286,589                
Purchase of Capped Calls   (100,000)                
Net loss (631,887)   (631,887)   (515,923)   (10,692)   (105,271)  
Other comprehensive income (loss), net of tax $ (1,182)     (1,182)            
Balance, end of period, shares at Jun. 30, 2020 1,463,620         1,204,957   24,215   234,448
Balance, end of period at Jun. 30, 2020 $ 2,194,665 9,773,857 (7,578,597) (609)   $ 12       $ 2
Balance, beginning of period, shares at Mar. 31, 2020           1,182,527   24,279   232,783
Balance, beginning of period at Mar. 31, 2020   9,380,435 (7,252,646) (2,896)   $ 12       $ 2
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares           2,348   391    
Shares issued in connection with exercise of stock options under stock-based compensation plans   20,478                
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares           19,627        
Conversion of stock to voting/non-voting common stock, shares           455   (455)    
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   1,665
Stock-based compensation expense   186,355                
Equity component of convertible senior notes, net   286,589                
Purchase of Capped Calls   (100,000)                
Net loss (325,951)   (325,951)   $ (266,759)   $ (5,462)   $ (53,730)  
Other comprehensive income (loss), net of tax $ 2,287     2,287            
Balance, end of period, shares at Jun. 30, 2020 1,463,620         1,204,957   24,215   234,448
Balance, end of period at Jun. 30, 2020 $ 2,194,665 $ 9,773,857 (7,578,597) $ (609)   $ 12       $ 2
Cumulative-effect adjustment from accounting changes     $ (780)